Marking a Milestone in Its Global Expansion Strategy By: Russ Spencer In a development widely recognized across the pharmaceutical industry as a major turning point for biosimilar access in Europe, Teva Pharmaceuticals International GmbH — a subsidiary of Teva Pharmaceutical Industries Ltd. — announced on Tuesday that the European Commission (EC) has granted marketing authorization […]
